Utrecht-based Vitestro, a startup on a mission to be the first to bring autonomous blood drawing technology to European hospitals, announced that it has raised €12M in a Series A round of funding.
The round was led by Silicon Valley-based Sonder Capital, a firm that backs early-stage medical technology companies.
The round also saw participation from existing investors and new private investors with experience in the clinical laboratory and MedTech industry.
Founded in 2017 by Toon Overbeeke and Brian Joseph, Vitestro aims to bring autonomous blood-drawing equipment to hospitals in Europe.
The company’s device combines AI-based, robotic needle insertion and ultrasound-guided 3D rebuilding to ensure precise and safe blood collection.
It has already tested its prototype on more than 1,000 individuals.
With a dedicated staff of about 50 skilled individuals, experienced in medical robotics, imaging software, AI, QA/RA, and business development, Vitestro claims to be currently making good progress toward achieving its goal.
The company has reported that clinical trials will resume in 2023, and a 2024 launch on the European market is expected.
Vitestro says it will use the funds to accelerate product development, prepare EU market authorization, and initiate production.
Read more on Tech Gist Africa:
Amsterdam-based agtech startup Source.ag bags €21.6M
